{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"75.000","rs_stock_flag":false,"fiscal_year_end":"31 Dec 2024","hist_closedate":"25 Sep 2025","replication_method":null,"amt_os":"163,428,541","primaryexch":"HKEX","ric":"2696.HK","product_subtype":null,"db_updatetime":"26 Sep 2025 18:38","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":1.5096,"inline_upper_strike_price":"","sedol":"BKLJK94","am":"70.13","iv":"","ew_strike":"","as":"71.550","geographic_focus":null,"incorpin":"PRC","etp_baseCur":null,"ew_amt_os":"","bd":"71.500","registrar":"Computershare Hong Kong Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"100","update_time":"2025-09-26 10:38:37.0","lo52":"15.200","shares_issued_date":"31 Aug 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"K","base_currency":null,"coupon":"","expiry_date":"","chairman":"Wenjie Zhang","underlying_ric":"2696.HK","hi52":"92.000","issuer_name":"Shanghai Henlius Biotech, Inc. - H Shares","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"26 Sep 2025 16:08","aum_date":"","lo":"71.250","mkt_cap":"11.69","f_aum_hkd":null,"ew_sub_per_to":"","ls":"71.550","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"-2.600","aum":"","issued_shares_class_B":null,"vo":"961.21","secondary_listing_flag":false,"listing_date":"25 Sep 2019","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"Shanghai Henlius Biotech, Inc. - H Shares","nm_s":"HENLIUS","sym":"2696","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.050","strike_price":"","summary":"Shanghai Henlius Biotech Inc is a China-based company principally engaged in biopharmaceutical research and development, biopharmaceutical services and biopharmaceutical production and sales. The Company’s main products include HANQUYOU (trastuzumab for injection), HANNAIJIA (neratinib maleate), HANSIZHUANG (serplulimab injection), HANLIKANG (rituximab injection), HANDAYUAN (adalimumab injection), HANBEITAI (bevacizumab injection) and others. The Company’s products are mainly used in the treatment of adjuvant breast cancer, metastatic breast cancer, metastatic gastric cancer, metastatic non-squamous non-small cell lung cancer, polyarticular juvenile idiopathic arthritis and others. The Company mainly operates its businesses in the domestic and overseas markets.","op":"74.150","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Biotechnology","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"Room 303, 304, Block 7<br/>No. 1999 Zhangheng Road<br/>China (Shanghai) Pilot<br/>Free Trade Zone, PRC","pc":"-3.51","days_to_expiry":null,"underlying_code":null,"pe":"44.73","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"74.150","isin":"CNE100003N76","moneyness":""}},"qid":"1758890182040"}
